Further evidence is available from a randomized trial by Simpson et al. [54] who reported that the macrolide clarithromycin decreased airway IL-8 and neutrophilia, and improved wheezing and asthma quality of life in subjects with severe, refractory asthma who were randomized to clarithromycin. The gene discussed is CXCL8; the disease is asthma.